Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 40.28
+0.90 (2.29%)
At close: Jun 27, 2025, 2:57 PM CST
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 5.15 billion as of July 1, 2025. Its market cap has increased by 22.88% in one year.
Market Cap
5.15B
Enterprise Value
3.81B
Revenue
301.21M
Ranking
n/a
PE Ratio
318.94
Stock Price
40.28
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 5.15B, a decrease of -50.65%. That is a compound annual growth rate of -22.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 5.11B | 23.20% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 343.54B |
| Shenzhen Mindray Bio-Medical Electronics | 271.81B |
| WuXi AppTec | 199.19B |
| Sichuan Biokin Pharmaceutical | 121.11B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.45B |
| Aier Eye Hospital Group | 114.62B |
| Shanghai United Imaging Healthcare | 105.00B |
| Yunnan Baiyao Group Co.,Ltd | 99.51B |